These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 25821809)

  • 1. Antioxidant strategies in the management of diabetic neuropathy.
    Oyenihi AB; Ayeleso AO; Mukwevho E; Masola B
    Biomed Res Int; 2015; 2015():515042. PubMed ID: 25821809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy.
    Kuhad A; Chopra K
    Neuropharmacology; 2009 Sep; 57(4):456-62. PubMed ID: 19555701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
    Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
    Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Natural Rotenoid Deguelin Ameliorates Diabetic Neuropathy by Decreasing Oxidative Stress and Plasma Glucose Levels in Rats via the Nrf2 Signalling Pathway.
    Chen J; Liu W; Yi H; Hu X; Peng L; Yang F
    Cell Physiol Biochem; 2018; 48(3):1164-1176. PubMed ID: 30045011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy.
    Bachewal P; Gundu C; Yerra VG; Kalvala AK; Areti A; Kumar A
    Biofactors; 2018 Mar; 44(2):109-122. PubMed ID: 29193444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrf2: a potential therapeutic target for diabetic neuropathy.
    Kumar A; Mittal R
    Inflammopharmacology; 2017 Aug; 25(4):393-402. PubMed ID: 28353124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy.
    Low PA; Nickander KK; Tritschler HJ
    Diabetes; 1997 Sep; 46 Suppl 2():S38-42. PubMed ID: 9285497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of oxidative stress in the development of diabetic neuropathy].
    Sztanek F; Molnárné Molnár Á; Balogh Z
    Orv Hetil; 2016 Dec; 157(49):1939-1946. PubMed ID: 27917671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model.
    Valsecchi AE; Franchi S; Panerai AE; Rossi A; Sacerdote P; Colleoni M
    Eur J Pharmacol; 2011 Jan; 650(2-3):694-702. PubMed ID: 21050844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives.
    van Dam PS
    Diabetes Metab Res Rev; 2002; 18(3):176-84. PubMed ID: 12112935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin: A potential drug in the management of diabetic neuropathy.
    Suarez-Mendez S; Tovilla-Zárate CA; Juárez-Rojop IE; Bermúdez-Ocaña DY
    Biomed Pharmacother; 2018 Sep; 105():956-961. PubMed ID: 30021390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loganin Ameliorates Painful Diabetic Neuropathy by Modulating Oxidative Stress, Inflammation and Insulin Sensitivity in Streptozotocin-Nicotinamide-Induced Diabetic Rats.
    Cheng YC; Chiu YM; Dai ZK; Wu BN
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-lipoic acid supplementation and diabetes.
    Singh U; Jialal I
    Nutr Rev; 2008 Nov; 66(11):646-57. PubMed ID: 19019027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative Stress in Diabetic Peripheral Neuropathy: Pathway and Mechanism-Based Treatment.
    Lin Q; Li K; Chen Y; Xie J; Wu C; Cui C; Deng B
    Mol Neurobiol; 2023 Aug; 60(8):4574-4594. PubMed ID: 37115404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.
    Stavniichuk R; Drel VR; Shevalye H; Maksimchyk Y; Kuchmerovska TM; Nadler JL; Obrosova IG
    Exp Neurol; 2011 Jul; 230(1):106-13. PubMed ID: 21515260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus.
    Poh ZX; Goh KP
    Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):392-8. PubMed ID: 19601918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Diabetic Neuropathy: Focus on Oxidative Stress.
    Pang L; Lian X; Liu H; Zhang Y; Li Q; Cai Y; Ma H; Yu X
    Oxid Med Cell Longev; 2020; 2020():9524635. PubMed ID: 32832011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sayyed SG; Kumar A; Sharma SS
    Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle.
    Negi G; Kumar A; Joshi RP; Sharma SS
    Biochem Biophys Res Commun; 2011 Apr; 408(1):1-5. PubMed ID: 21439933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escin alleviates peripheral neuropathy in streptozotocin induced diabetes in rats.
    Suryavanshi SV; Kulkarni YA
    Life Sci; 2020 Aug; 254():117777. PubMed ID: 32407839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.